Effect of warm and cold ischemia on pancreaticoduodenectomy specimen following robotic pancreaticoduodenectomy
- PMID: 39501227
- PMCID: PMC11536913
- DOI: 10.1186/s12893-024-02652-4
Effect of warm and cold ischemia on pancreaticoduodenectomy specimen following robotic pancreaticoduodenectomy
Abstract
Background: The adoption of robotic pancreaticoduodenectomy (PD) has increased in recent years for the treatment of pancreatic head tumors and periampullary lesions. Some potential benefits seem to be demonstrated; however, obtaining specimens through this method can potentially compromise the diagnosis depending on the timing of the specimen retrieval, and the impact of longer perioperative time on ischemia and autolysis of the surgical specimen has not been analyzed. The aim of this study is to evaluate the histological changes associated with timing of specimen retrieval during robotic PD.
Methods: A review of histopathology files was performed for all pancreatic specimens collected at our hospital from January 2022 to March 2024. Both warm ischemia time (WIT) and cold ischemia time (CIT) were collected. Histological features related to ischemic damage were evaluated in normal duodenal and pancreatic parenchyma as well as pancreatic tumor, and were graded as: absent, mild, moderate and severe. Univariate and multivariate analyses were performed to determine which variables were associated with moderate and severe ischemic changes.
Results: Sixty surgical specimens were analyzed: 20 open PD, 17 robotic PD with cold ischemia, and 23 robotic PD. Median total WIT was 182 min (open PD 57 min vs. RPD 190 min vs. RPD-CI 198 min; p < 0.001). Median CIT was 760 min (740-835) in samples stored at 4ºC. Univariate analysis showed that longer intraoperative time, male gender and cold ischemia were associated with pancreatic tissue ischemic changes. In multivariate analysis, cold ischemia was the only independent factor associated with normal pancreatic tissue and tumor tissue moderate and severe ischemic changes.
Conclusions: Prolonged ischemia time, especially in the case of cold storage, has a strong effect on the degradation of normal and tumor tissue without affecting pathological evaluation. Operative teams should aim to optimize both the duration and efficiency of the surgical procedure, ensuring minimal ischemic time. Simultaneously, pathology departments must be equipped to process pancreatic specimens promptly, with protocols in place to minimize the time between resection and analysis.
Keywords: Cold ischemia; Robotic pancreaticoduodenectomy; Specimen damage; Warm ischemia.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Is robotic pancreaticoduodenectomy non-inferior to open pancreaticoduodenectomy in patients with high PD-ROBOSCORE?Surg Endosc. 2025 Apr;39(4):2364-2369. doi: 10.1007/s00464-025-11550-6. Epub 2025 Feb 18. Surg Endosc. 2025. PMID: 39966133 Free PMC article.
-
Surgical, survival, and oncological outcomes after vascular resection in robotic and open pancreaticoduodenectomy.Surg Endosc. 2020 Jan;34(1):377-383. doi: 10.1007/s00464-019-06779-x. Epub 2019 Apr 8. Surg Endosc. 2020. PMID: 30963260
-
A Multi-institutional Comparison of Perioperative Outcomes of Robotic and Open Pancreaticoduodenectomy.Ann Surg. 2016 Oct;264(4):640-9. doi: 10.1097/SLA.0000000000001869. Ann Surg. 2016. PMID: 27433907
-
Robotic-assisted versus open pancreaticoduodenectomy for patients with benign and malignant periampullary disease: a systematic review and meta-analysis of short-term outcomes.Surg Endosc. 2020 Jun;34(6):2390-2409. doi: 10.1007/s00464-020-07460-4. Epub 2020 Feb 18. Surg Endosc. 2020. PMID: 32072286
-
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?Expert Rev Gastroenterol Hepatol. 2024 Apr-May;18(4-5):133-139. doi: 10.1080/17474124.2024.2351398. Epub 2024 May 10. Expert Rev Gastroenterol Hepatol. 2024. PMID: 38712525 Review.
References
-
- Pancreas cancer. World Health Organization. [on-line: https://platform.who.int/mortality/themes/theme-details/topics/indicator...]
-
- Mihaljevic A, Al-Saeedi M, Hackert T. Pancreatic surgery: we need clear definitions. Langenbeck’s Archives Surg. 2019;404(2):159–65. 10.1007/s00423-018-1725-7. - PubMed
-
- Ausania F, Gonzalez-Abós C, Martinez-Perez A, Arrocha C, Pineda-Garcés C, Landi F, Fillat C, Garcia-Valdecasas JC. Postoperative day one systemic inflammatory response syndrome is a powerful early biomarker of clinically relevant pancreatic fistula. HPB: Official J Int Hepato Pancreato Biliary Association. 2023;25(1):73–80. 10.1016/j.hpb.2022.08.016. - PubMed
-
- Ausania F, Martínez-Pérez A, Rio SD, Borin P, Melendez A, R., Casal-Nuñez JE. Multifactorial mitigation strategy to reduce clinically relevant pancreatic fistula in high-risk pancreatojejunostomy following pancreaticoduodenectomy. Pancreatology: Official J Int Association Pancreatology (IAP) … et al ]. 2021;21(2):466–72. 10.1016/j.pan.2020.12.019. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical